Mirae Asset Global Investments’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,734
Closed -$84.3K 1666
2025
Q3
$84.3K Buy
5,734
+95
+2% +$968 ﹤0.01% 1249
2025
Q2
$55.4K Buy
5,639
+788
+16% +$6.53K ﹤0.01% 1241
2025
Q1
$39.2K Buy
4,851
+933
+24% +$8.16K ﹤0.01% 1287
2024
Q4
$30.9K Buy
3,918
+87
+2% +$716 ﹤0.01% 1352
2024
Q3
$27.8K Buy
3,831
+894
+30% +$7.52K ﹤0.01% 1390
2024
Q2
$22.1K Sell
2,937
-13,787
-82% -$123K ﹤0.01% 1370
2024
Q1
$195K Sell
16,724
-28,920
-63% -$320K ﹤0.01% 2271
2023
Q4
$510K Buy
45,644
+3,278
+8% +$30.1K ﹤0.01% 1963
2023
Q3
$654K Sell
42,366
-1,333
-3% -$22.4K ﹤0.01% 1753
2023
Q2
$811K Buy
43,699
+30,348
+227% +$533K ﹤0.01% 1691
2023
Q1
$203K Buy
+13,351
New +$174K ﹤0.01% 2325

Other funds holding ETNB

Mirae Asset Global Investments's ETNB Position: Q4 2025 in Review

Mirae Asset Global Investments sold out of 89bio (ETNB) in Q4 2025, closing a stake of 5,734 shares — an estimated $84.3K sold.

Mirae Asset Global Investments first reported a position in ETNB in Q1 2023 and held it in 11 quarters. The position peaked at $811K in Q2 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Mirae Asset Global Investments reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 5,734 89bio shares in Q4 2025, an estimated $84.3K.
  • Mirae Asset Global Investments first reported a position in 89bio in Q1 2023 and held it in 11 quarters.
  • Mirae Asset Global Investments's 89bio position peaked at $811K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.